AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8119084 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative extracorporeal shock‐wave lithotripsy (ESWL)
Number of subjects: 10
Study 8119084 — intervention group
Group type: COMPARATOR
Intervention: Mechanical lithotripsy
Number of subjects: 10
Study 3508426 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO (hydroxyl radical scavenger), administered locally 5 times a day for one week
Number of subjects: 0
Study 3508426 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered for one week
Number of subjects: 0
Study 31961756 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial tourniquet
Number of subjects: 246
Study 31961756 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvised tourniquet
Number of subjects: 246
Study 28922211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonia inhalant (AI)
Number of subjects: 20
Study 28922211 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study 28922211 — intervention group
Group type: COMPARATOR
Intervention: No inhalants (N)
Number of subjects: 20
Study 26879839 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 56
Study 26879839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 24887747 — intervention group
Group type: COMPARATOR
Intervention: Topical clobetasol propionate 0.05% applied three times a day
Number of subjects: 42
Study 24887747 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser phototherapy (LPT) using InGaAlP diode laser applied three times a week
Number of subjects: 42
Study 22383268 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive group therapy
Number of subjects: 100
Study 22383268 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 100
Study 20646425 — intervention group
Group type: EXPERIMENTAL
Intervention: HCC > 10 cm group
Number of subjects: 316
Study 18387775 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal perfusion with venous blood
Number of subjects: 158
Study 18387775 — intervention group
Group type: COMPARATOR
Intervention: Suprarenal clamping without renal perfusion
Number of subjects: 158
Study 16423104 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 30
Study 16423104 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 30
Study 16423104 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study 12592681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hejie Decoction (HJD)
Number of subjects: 45
Study 12592681 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine (Control)
Number of subjects: 45
Study 10599260 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg once or twice a day)
Number of subjects: 1989
Study 10599260 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (3 g/d), Amoxicillin/clavulanic acid (1500 mg/d), Ceftriaxone (1-4 g/d)
Number of subjects: 1989
Study 10599260 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (in patients with bacteriemia)
Number of subjects: 1989
Study 10599260 — intervention group
Group type: COMPARATOR
Intervention: Comparators (in patients with bacteriemia)
Number of subjects: 1989
Study 7499116 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoxan
Number of subjects: 36
Study 7499116 — intervention group
Group type: COMPARATOR
Intervention: Cytoxan
Number of subjects: 36
Study 7499116 — intervention group
Group type: COMPARATOR
Intervention: Investigational direct compression tablet
Number of subjects: 36
Study 1449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids in combination with albuterol
Number of subjects: 15
Study 1449568 — intervention group
Group type: COMPARATOR
Intervention: Control group with different corticosteroids in combination with albuterol
Number of subjects: 15
Study 4023255 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium 201 stress testing on treadmill (Tl-TM)
Number of subjects: 50
Study 4023255 — intervention group
Group type: COMPARATOR
Intervention: Supine bicycle-ergometer-exercise thallium 201 testing (Tl-SB)
Number of subjects: 50
Study 30630425 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting the epiglottis using stylets with a bend angle of 35°
Number of subjects: 32
Study 30630425 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting the epiglottis using stylets with a bend angle of 50°
Number of subjects: 32
Study 30630425 — intervention group
Group type: COMPARATOR
Intervention: Not lifting the epiglottis
Number of subjects: 32
Study 30289802 — intervention group
Group type: COMPARATOR
Intervention: Asha-support only (control group)
Number of subjects: 0
Study 30289802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 0
Study 30289802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplementation
Number of subjects: 0
Study 30289802 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nutrition supplementation and education
Number of subjects: 0
Study 25182269 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care model
Number of subjects: 860
Study 25182269 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 860
Study 21553949 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect video induction
Number of subjects: 200
Study 21553949 — intervention group
Group type: COMPARATOR
Intervention: Neutral video induction
Number of subjects: 200
Study 21553949 — intervention group
Group type: COMPARATOR
Intervention: Neutral writing technique induction
Number of subjects: 200
Study 21553949 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect writing technique induction
Number of subjects: 200
Study 20660677 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg intravenous infusion of PRO 140
Number of subjects: 31
Study 20660677 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg intravenous infusion of PRO 140
Number of subjects: 31
Study 20660677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 17986493 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac-resynchronization therapy (CRT)
Number of subjects: 172
Study 17986493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CRT)
Number of subjects: 172
Study 17986493 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT (in subgroup with QRS interval of 120 msec or more)
Number of subjects: 172
Study 17986493 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT (in subgroup with QRS interval of less than 120 msec)
Number of subjects: 172
Study 17986493 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT
Number of subjects: 172
Study 16321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine vaccine (200 microg)
Number of subjects: 68
Study 16321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine vaccine (50 microg)
Number of subjects: 68
Study 16321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine vaccine (100 microg)
Number of subjects: 68
Study 16321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine vaccine (50, 100, 200 microg)
Number of subjects: 68
Study 16321612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 12581507 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP 200 microg bid via HFA-134a
Number of subjects: 172
Study 12581507 — intervention group
Group type: COMPARATOR
Intervention: BDP 200 microg bid via CFC
Number of subjects: 172
Study 9833072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization technique (FISH)
Number of subjects: 189
Study 9833072 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromosomal abnormalities in recurrent meningiomas
Number of subjects: 189
Study 9833072 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathological and cytogenetic correlations
Number of subjects: 189
Study 8065789 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural patient-controlled analgesia (PCA) with 0.125% plain bupivacaine
Number of subjects: 60
Study 8065789 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion system with 0.125% plain bupivacaine
Number of subjects: 60
Study 2903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1 mg kg‐1
Number of subjects: 44
Study 2903604 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 44
Study 31645442 — intervention group
Group type: EXPERIMENTAL
Intervention: NZ8123-HPV16-optiE7 vaccine (5 × 109 CFU/mL)
Number of subjects: 55
Study 31645442 — intervention group
Group type: EXPERIMENTAL
Intervention: NZ8123-HPV16-optiE7 vaccine (1 × 1010 CFU/mL)
Number of subjects: 55
Study 31645442 — intervention group
Group type: EXPERIMENTAL
Intervention: NZ8123-HPV16-optiE7 vaccine (1 × 109 CFU/mL)
Number of subjects: 55
Study 31645442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 28620764 — intervention group
Group type: EXPERIMENTAL
Intervention: Bullying (frequently and upset)
Number of subjects: 6667
Study 28620764 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisocial/aggressive behavior (measured by ESYTC scale)
Number of subjects: 6667
Study 28882405 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300mg
Number of subjects: 32
Study 28882405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23625906 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (A, C, E and selenium) for 1 month
Number of subjects: 39
Study 23625906 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exposed to solvents)
Number of subjects: 39
Study 24395985 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal digital assistant-delivered communication intervention
Number of subjects: 50
Study 24395985 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 21178606 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblique fluoroscopic stellate block
Number of subjects: 50
Study 21178606 — intervention group
Group type: COMPARATOR
Intervention: Anterior paratracheal stellate block
Number of subjects: 50
Study 18485485 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (omega-3 fatty acids)
Number of subjects: 31
Study 18485485 — intervention group
Group type: COMPARATOR
Intervention: Mineral oil (placebo)
Number of subjects: 31
Study 16756780 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrostatic membrane sweeping (group-B)
Number of subjects: 50
Study 16756780 — intervention group
Group type: COMPARATOR
Intervention: Foley's catheter ballooning (group-A)
Number of subjects: 50
Study 14603951 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced red cells/fresh frozen plasma using a high efficiency filter at the bedside
Number of subjects: 87
Study 14603951 — intervention group
Group type: COMPARATOR
Intervention: Buffycoat-depleted red cells transfused through an aggregate filter
Number of subjects: 87
Study 11072157 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemo-radiation (4760 cGy to primary and lymph nodes with concurrent chemotherapy: cisplatin/5-FU)
Number of subjects: 46
Study 11072157 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemo-radiation
Number of subjects: 46
Study 8650989 — intervention group
Group type: COMPARATOR
Intervention: High performance weight lifters
Number of subjects: 40
Study 8650989 — intervention group
Group type: COMPARATOR
Intervention: Sports-boxers
Number of subjects: 40
Study 8650989 — intervention group
Group type: COMPARATOR
Intervention: Tour de France bikers
Number of subjects: 40
Study 1547683 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 10
Study 1547683 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork insulin
Number of subjects: 10
Study 3884408 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam (oral drops)
Number of subjects: 20
Study 3884408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31703302 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-social services (six sessions)
Number of subjects: 248
Study 29870596 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin with Tramadol
Number of subjects: 0
Study 29870596 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin with Ethanol
Number of subjects: 0
Study 29870596 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin with Lorazepam
Number of subjects: 0
Study 29870596 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin with Zolpidem
Number of subjects: 0
Study 29870596 — intervention group
Group type: COMPARATOR
Intervention: Mirogabalin alone
Number of subjects: 0
Study 27142873 — intervention group
Group type: EXPERIMENTAL
Intervention: INCA® device feedback and inhaler technique training
Number of subjects: 75
Study 27142873 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaler technique training (comparator group)
Number of subjects: 75
Study 27142873 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 75
Study 23912798 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + IFX
Number of subjects: 112
Study 23912798 — intervention group
Group type: COMPARATOR
Intervention: MTX + intravenous steroid
Number of subjects: 112
Study 22982023 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) treatment for 30 months
Number of subjects: 110
Study 22982023 — intervention group
Group type: COMPARATOR
Intervention: Placebo after stopping ICS treatment for 24 months
Number of subjects: 110
Study 20381890 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered intervention to assist patients in formulating plans for self-monitoring of blood glucose (SMBG)
Number of subjects: 402
Study 20381890 — intervention group
Group type: COMPARATOR
Intervention: Control groups (three control groups used to control for testing effects)
Number of subjects: 402
Study 18442341 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity interventions
Number of subjects: 39
Study 15990571 — intervention group
Group type: EXPERIMENTAL
Intervention: 3TC/ddI/EFV
Number of subjects: 77
Study 15990571 — intervention group
Group type: COMPARATOR
Intervention: TDF/ddI/EFV
Number of subjects: 77
Study 11889577 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (vitamin E 500 mg/day, beta-carotene 30 mg/day, vitamin C 1 g/day for last 15 days)
Number of subjects: 0
Study 11889577 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail
Number of subjects: 0
Study 11889577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10071350 — intervention group
Group type: EXPERIMENTAL
Intervention: Microemulsion formulation of cyclosporine
Number of subjects: 9
Study 10071350 — intervention group
Group type: COMPARATOR
Intervention: Original formulation of cyclosporine
Number of subjects: 9
Study 7675951 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 75 mg
Number of subjects: 0
Study 7675951 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 150 mg
Number of subjects: 0
Study 7675951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2286708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine (10-30 mg/day)
Number of subjects: 86
Study 2286708 — intervention group
Group type: COMPARATOR
Intervention: Amobarbital sodium for agitation
Number of subjects: 86
Study 7434788 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200-400 mg/day for 4 weeks
Number of subjects: 20
Study 7434788 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg in 10 healthy volunteers
Number of subjects: 20
Study 30707090 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive training
Number of subjects: 30
Study 30707090 — intervention group
Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 30
Study 27718637 — intervention group
Group type: EXPERIMENTAL
Intervention: New L-T4 formulation (600 μg)
Number of subjects: 0
Study 27718637 — intervention group
Group type: COMPARATOR
Intervention: Current L-T4 formulation (600 μg)
Number of subjects: 0
Study 27718637 — intervention group
Group type: EXPERIMENTAL
Intervention: L-T4 tablets (50 μg, 100 μg, 200 μg)
Number of subjects: 0
Study 25284802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 360
Study 25284802 — intervention group
Group type: COMPARATOR
Intervention: RFA
Number of subjects: 360
Study 23659489 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized heat stimulus applied to the forearm
Number of subjects: 75
Study 21860291 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven packs of OCPs
Number of subjects: 700
Study 21860291 — intervention group
Group type: COMPARATOR
Intervention: Three packs of OCPs
Number of subjects: 700
Study 21860291 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven packs of OCPs (younger than 18 years)
Number of subjects: 700
Study 21860291 — intervention group
Group type: COMPARATOR
Intervention: Three packs of OCPs (younger than 18 years)
Number of subjects: 700
Study 21860291 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven packs of OCPs (18 years and older)
Number of subjects: 700
Study 21860291 — intervention group
Group type: COMPARATOR
Intervention: Three packs of OCPs (18 years and older)
Number of subjects: 700
Study 21860291 — intervention group
Group type: COMPARATOR
Intervention: Prescription for refills
Number of subjects: 700
Study 21860291 — intervention group
Group type: EXPERIMENTAL
Intervention: Packs of OCPs
Number of subjects: 700
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: Coagulopathic patients (abnormal laboratory tests)
Number of subjects: 72
Study 19901655 — intervention group
Group type: COMPARATOR
Intervention: Noncoagulopathic patients (normal laboratory tests)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal international normalized ratio (INR)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal platelet count (PLT)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Abbreviated Injury Scale (AIS)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: Head AIS (multiple logistic regression)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: PLT (multiple logistic regression)
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients with abnormal partial thromboplastin time
Number of subjects: 72
Study 19901655 — intervention group
Group type: EXPERIMENTAL
Intervention: ICH progression
Number of subjects: 72
Study 16427057 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-directed protocolised-weaning
Number of subjects: 140
Study 16427057 — intervention group
Group type: COMPARATOR
Intervention: Usual doctor-led practice (Control)
Number of subjects: 140
Study 15549369 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot treatment (immersion in hot water at 43 degrees C for 16.0 min)
Number of subjects: 7
Study 15549369 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot treatment
Number of subjects: 7
Study 11572325 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy
Number of subjects: 0
Study 11572325 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) and oxandrolone therapy
Number of subjects: 0
Study 9260058 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autotransplantation
Number of subjects: 0
Study 9260058 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive therapy (bisphosphonates and erythropoietin)
Number of subjects: 0
Study 9260058 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic transplantation
Number of subjects: 0
Study 8485269 — intervention group
Group type: COMPARATOR
Intervention: MaxEPA
Number of subjects: 43
Study 8485269 — intervention group
Group type: COMPARATOR
Intervention: Super evening primrose oil
Number of subjects: 43
Study 8485269 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 43
Study 3663884 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose administration of quinidine gluconate and procainamide hydrochloride
Number of subjects: 0
Study 3663884 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose administration of quinidine gluconate and procainamide hydrochloride
Number of subjects: 0
Study 28540562 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based oral fluid rapid HIV self-testing
Number of subjects: 425
Study 28540562 — intervention group
Group type: COMPARATOR
Intervention: Mail-in blood sample collection HIV test
Number of subjects: 425
Study 28540562 — intervention group
Group type: COMPARATOR
Intervention: Medical facility/community organization-based HIV testing
Number of subjects: 425
Study 26252950 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito for 8 weeks
Number of subjects: 125
Study 25070393 — intervention group
Group type: EXPERIMENTAL
Intervention: CyClean
Number of subjects: 30
Study 25070393 — intervention group
Group type: EXPERIMENTAL
Intervention: MeniCare
Number of subjects: 30
Study 25070393 — intervention group
Group type: EXPERIMENTAL
Intervention: ReNu
Number of subjects: 30
Study 25070393 — intervention group
Group type: COMPARATOR
Intervention: Control (blister pack solution)
Number of subjects: 30
Study 25070393 — intervention group
Group type: EXPERIMENTAL
Intervention: Regard
Number of subjects: 30
Study 23127342 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Salmeterol/fluticasone (SF) delivered by a metered-dose inhaler with a spacer
Number of subjects: 19
Study 23127342 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nebulized ipratropium/terbutaline/budesonide (ITB)
Number of subjects: 19
Study 23127342 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Salmeterol/fluticasone (SF)
Number of subjects: 19
Study 20223394 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-axis approach
Number of subjects: 39
Study 20223394 — intervention group
Group type: COMPARATOR
Intervention: Short-axis approach
Number of subjects: 39
Study 18515448 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day taper
Number of subjects: 28
Study 18515448 — intervention group
Group type: COMPARATOR
Intervention: 14-day taper
Number of subjects: 28
Study 18515448 — intervention group
Group type: EXPERIMENTAL
Intervention: short half-life antidepressants
Number of subjects: 28